• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
Search 
  •   COVID-19
  • Search
  •   COVID-19
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 285

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
  • Thumbnail

    The Australian and New Zealand Intensive Care Society (ANZICS) COVID-19 Guidelines 

    Australian and New Zealand Intensive Care Society
    An Operational Guide for Intensive Care Units in Australia and New Zealand
  • Thumbnail

    Additional steroid treatment for patients with influenza who are critically ill: Uncertain whether beneficial or harmful 

    Allen, Claire (2020-03-16)
    What is this? Corticosteroids are widely used for people with severe influenza, but there is uncertainty about their potential benefits or harms. Corticosteroids have shown evidence of benefit in sepsis and related conditions, ...
  • Thumbnail

    Enteral, parenteral nutrition and their combination for adults in the intensive care unit 

    Allen, Claire (2020-03-17)
    What is this? Some patients with COVID-19 will become critically ill and need treatment in an intensive care unit (ICU). This may interrupt their feeding routines and reduce appetite or increase nausea and vomiting, leading ...
  • Thumbnail

    Chinese herbs combined with Western medicine in the treatment of severe acute respiratory syndrome (SARS) 

    Allen, Claire (2020-03-19)
    What is this? The first cases of severe acute respiratory syndrome (SARS) were reported in December 2002. This is an acute respiratory disease caused by a coronavirus and integrated Chinese and Western medicines may have ...
  • Thumbnail

    Buffered solutions did not reduce mortality compared to 0.9% saline for resuscitation in critically ill adults and children 

    Allen, Claire (2020-03-22)
    What is this? Some patients with COVID-19 will become critically ill and need intravenous fluids. Saline 0.9% is the most commonly used crystalloid solutions for critically ill patients, but buffered solutions are also ...
  • Thumbnail

    Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China 

    Dong Y et al. Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China (2020-03-20)
    OBJECTIVES: To identify the epidemiological characteristics and transmission patterns of pediatric patients with COVID-19 in China. METHODS: Nationwide case series of 2143 pediatric patients with COVID-19 reported to the ...
  • Thumbnail

    Extracorporeal membrane oxygenation (ECMO) for patients with acute respiratory failure: Uncertain if it is better or worse than conventional lung support 

    Allen, Claire (2020-03-18)
    What is this? Some patients with COVID-19 will become critically ill and need help with their breathing. Extracorporeal membrane oxygenation (ECMO) is a form of life support that targets the heart and lungs and which might ...
  • Thumbnail

    High levels of PEEP are not better than low levels for reducing mortality in adult ICU patients with acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) 

    Allen, Claire (2020-03-18)
    What is this? Some patients with COVID-19 will develop acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) and need help with their breathing. This might be provided by mechanical ventilation (MV) in an ...
  • Thumbnail

    Drugs for treating acute respiratory distress syndrome (ARDS) in critically ill patients 

    Allen, Claire (2020-03-16)
    What is this? Some patients with COVID-19 will develop acute respiratory distress syndrome (ARDS) and need help with their breathing. ARDS is caused by direct or indirect injury to the lungs and about 40% of people with ...
  • Thumbnail

    Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19. 

    Xu T et al. Institute of Hepatology, the Third People's Hospital of Changzhou, Changzhou, China; Department of Infectious Diseases, the Third People's Hospital of Changzhou, Changzhou, China (2020-03-07)
    OBJECTIVES: To compare the clinical characteristics and the dynamics of viral load between the imported and non-imported patients with COVID-19. DESIGN AND METHODS: Data from 51 laboratory-confirmed patients were retrospectively ...
  • 1
  • 2
  • 3
  • 4
  • . . .
  • 29

Discover

Category
Clinical characterization and management (285)
Virus: natural history, transmission and diagnostics (28)Infection prevention and control, including health care workers protection (25)Health systems and services (13)Epidemiology and epidemiological studies (9)Candidate therapeutics RD (7)Social sciences in the response (2)Candidate vaccines RD (1)Emergency medical services, medical transport and 911 (1)Ethical considerations for research (1)... View MoreLanguageEnglish (265)Français (11)TypePublished Article (223)Other publications (39)Research protocol information (18)Other public health institution guidance (5)AuthorAllen, Claire (34)BMJ Best Practice (2)CDC COVID-19 Response Team (2)Chen, Guang et al. (2)Chen, Juan et al. (2)Kwok, Gabriel (2)National Institute for Health and Care Excellence (2)Abubakar, Abdullahi Rabiu et al. (1)Abuelgasim, Eyad et al. (1)Acheampong, Desmond Omane et al. (1)... View MoreSubjectCOVID-19 (262)Coronavirus (234)Infectious Diseases (231)Coronavirus Infections (108)SARS-CoV-2 (58)Betacoronavirus (45)Systematic Review (24)Mortality (22)Pandemics (20)Meta-Analysis (19)... View MoreDate Issued2020 (276)2021 (2)2014 (1)2015 (1)2018 (1)Country
Others (285)

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)